Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.
about
Choline analogues in malaria chemotherapyGenome-wide analysis of gene expression and protein secretion of Babesia canis during virulent infection identifies potential pathogenicity factors.A systematic approach to understand the mechanism of action of the bisthiazolium compound T4 on the human malaria parasite, Plasmodium falciparumSymmetrical choline-derived dications display strong anti-kinetoplastid activity.Targeting the Lipid Metabolic Pathways for the Treatment of Malaria.PG12, a phospholipid analog with potent antimalarial activity, inhibits Plasmodium falciparum CTP:phosphocholine cytidylyltransferase activity.Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel).Recent highlights in antimalarial drug resistance and chemotherapy research.Arylmethylamino steroids as antiparasitic agents.Quaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions?Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).High Accumulation and In Vivo Recycling of the New Antimalarial Albitiazolium Lead to Rapid Parasite Death.New insight into the mechanism of accumulation and intraerythrocytic compartmentation of albitiazolium, a new type of antimalarial.Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidateEffect of a bis-thiazolium compound on the biosynthesis of Plasmodium falciparum phospholipids.
P2860
Q26851323-1C0F3A97-1B73-46A8-9EFC-435326207662Q30855654-DF8DFBA0-FA7F-4A74-9500-FB74FC5E8D21Q33381401-AF1BB000-ACEC-4A61-B435-583FEB03D82BQ33747243-0455DB63-A77F-4C93-916A-01046FC7FD5CQ33915847-25C00AA5-75C0-470E-9684-4C6E065A4B78Q35309698-F127D6B4-59D9-4748-8E9E-D7D47FD9B16FQ36478925-357195B8-FE1E-4C44-9E56-02C2F18C4DAFQ37283037-4B7762A6-60CC-4BBD-8B40-A6E34DE23F00Q37660615-F9F59314-811B-4C00-BD5E-404BFA0AD3F7Q37960432-E1ADDF37-F1EA-45DA-A55D-A4D449D0DA20Q39115683-5B7DB22C-E544-47B4-9529-9563F419DE1CQ40175227-9415D3EF-0D11-494F-AC12-36A84D08752BQ41920840-F1BE5FAD-A232-4903-BBB6-7593D7458644Q42324155-D03D408F-6050-41B0-99C9-B1840083509CQ46113202-EDCA0FA6-AA98-4D83-B93D-E7F0865C04D3
P2860
Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Potent antihematozoan activity ...... th Babesia and Plasmodium spp.
@ast
Potent antihematozoan activity ...... th Babesia and Plasmodium spp.
@en
type
label
Potent antihematozoan activity ...... th Babesia and Plasmodium spp.
@ast
Potent antihematozoan activity ...... th Babesia and Plasmodium spp.
@en
prefLabel
Potent antihematozoan activity ...... th Babesia and Plasmodium spp.
@ast
Potent antihematozoan activity ...... th Babesia and Plasmodium spp.
@en
P2093
P2860
P356
P1476
Potent antihematozoan activity ...... ith Babesia and Plasmodium spp
@en
P2093
Eric Precigout
Eric Richier
Frederic Boudou
Henri J Vial
Jean-François Dubremetz
Michèle Calas
Patrick G Bray
Sharon Wein
P2860
P304
P356
10.1128/AAC.00443-06
P407
P577
2006-10-01T00:00:00Z